Image 1
Chemical structure diagram of estradiol, an active ingredient in Mimvey. The structure shows multiple fused rings and hydroxyl groups (OH).*
Mimvey Tablet, Film Coated
Product Images NDC 0093-5455
11 FDA label images from Teva Pharmaceuticals Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Mimvey (NDC 0093-5455). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Mimvey ® (estradiol And Norethindrone Acetate Tablets Usp) 1 mg/0.5 mg 5 X 28 Carton, Part 1 Of 2 (Image 10)
Mimvey Estradiol and Norethindrone Acetate 1 mg/0.5 mg film-coated tablet 28-day oral blister pack by Teva Pharmaceuticals USA, Inc. The blister features seven columns labeled Sunday through Saturday and four rows for weekly dosing, with designated places for 28 tablets.*
Mimvey ® (estradiol And Norethindrone Acetate Tablets Usp) 1 mg/0.5 mg 5 X 28 Carton, Part 2 Of 2 (Image 11)
Packaging label for Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg oral film-coated tablets. The box contains 1 blister card with 28 tablets arranged in a 28-day regimen. Labeler is Teva Pharmaceuticals USA, Inc. The label includes dosage information, storage instructions, barcodes, and the Teva logo.*
Image 2
Chemical structure of Estradiol and Norethindrone Acetate, the active ingredients in Mimvey tablets. The diagram shows the steroid backbone with characteristic functional groups including keto and acetate moieties.*
Image 3
A line graph showing concentration (pg/ml) over time (hours) for Estradiol and Estrone. Estradiol concentrations peak early and then decline gradually over 24 hours, while Estrone concentrations rise sharply to a higher peak around 4 hours before gradually decreasing over the remainder of the 24-hour period.*
Image 4
A pharmacokinetic curve depicting concentration (ng/ml) on the y-axis versus time (hours) on the x-axis, showing a rapid increase followed by a gradual decline over a 24-hour period.*
Image 5
A line chart comparing the number of moderate to severe hot flushes per week over 12 weeks among three groups: placebo, 1 mg estradiol, and Mimvey 1 mg/0.5 mg. The y-axis represents the number of hot flushes per week, and the x-axis represents weeks from 0 to 12, showing a decreasing trend in symptoms for the treatment groups compared to placebo.*
Image 6
A line graph depicting the number of moderate to severe hot flushes over a 12-week period. It compares two groups: one receiving Estradiol and Norethindrone Acetate 0.5 mg/0.1 mg (n=194) and the other receiving a placebo (n=199). The graph shows a decline in hot flushes for the treatment group compared to the placebo group over time.*
Image 7
A line graph comparing the percentage of women across 12 cycles between Mimvey and 1 mg Estradiol (E2). The vertical axis shows % Women ranging from 40 to 90, and the horizontal axis shows cycle numbers from 1 to 12. Mimvey shows a higher percentage of women over cycles compared to 1 mg E2.*
Image 8
A line graph comparing the percentage of women over six cycles receiving Estradiol and Norethindrone Acetate 0.5 mg/0.1 mg tablets versus placebo. The y-axis represents percentage of women from 40% to 100%, and the x-axis represents the number of cycles from 1 to 6, showing increasing trends in both groups with placebo consistently higher.*
Image 9
A line graph showing percent change over 28 lunar months (28-day cycles) for different groups including Mimvey 1 mg/0.5 mg in EU and US, Estradiol 0.5 mg in the US, and placebo groups in both EU and US. The y-axis represents percentage change, and the x-axis represents time in lunar months with error bars for variability.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
